A Noncationic Biocatalytic Nanobiohybrid Platform for Cytosolic Protein Delivery Through Controlled Perturbation of Intracellular Redox Homeostasis
Small · 2024
DOI: 10.1002/smll.202407676 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Wanyue Lu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Department of Chemistry, Fudan University, Shanghai, 200433, China. Hauptthemen laut MEDLINE: Oxidation-Reduction, Glucose Oxidase, Homeostasis, Cytosol. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Australia National Health and Medical Research Council.
Abstract (Originalsprache)
Intracellular delivery of proteins has largely been relying on cationic nanoparticles to induce efficient endosome escape, which, however, poses serious concerns on the inflammatory and cytotoxic effects. Herein, a versatile noncationic nano biohybrid platform is introduced for efficient cytosolic protein delivery by utilizing a nano‐confined biocatalytic reaction. This platform is constructed by co‐immobilizing glucose oxidase (GOx) and the target protein into nanoscale hydrogen‐bonded organic frameworks (HOFs). The biocatalytic reaction of nano‐confined GOx is leveraged to induce controlled perturbation of intracellular redox homeostasis by sustained hydrogen peroxide (H 2 O 2 ) production and diminishing the flux of the pentose phosphate pathway (PPP). This in turn induces the endosome escape of nanobiohybrids. Concomitantly, GOx‐mediated hypoxia leads to overexpression of azo reductase that initiated the materials' self‐destruction for releasing target proteins. These biological effects collectively induce highly efficient cytosolic protein delivery. The versatility of this delivery platform is further demonstrated for various types of proteins, different protein loading approaches (in situ immobilization or post‐adsorption), and in multiple cell lines. Finally, the protein delivery efficiency and biosafety are demonstrated in a tumor‐bearing mouse model. This nanohybrid system opens up new avenues for intracellular protein delivery and is expected to be extensively applicable for a broad range of biomolecuels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials, Department of Chemistry, Fudan University, Shanghai, 200433, China.
- South Australian ImmunoGENomic Cancer Institute, The University of Adelaide, Adelaide, South Australia, 5005, Australia.
- Institute of Optoelectronics, Fudan University, Shanghai, 200433, China.
ORCID-Profile: Yannan Yang
Förderung
- National Natural Science Foundation of China
- Australia National Health and Medical Research Council
Zitieren
APA
Lu, W., Wang, W., Gong, Y., Li, J., Zhou, Y., & Yang, Y. (2024). A Noncationic Biocatalytic Nanobiohybrid Platform for Cytosolic Protein Delivery Through Controlled Perturbation of Intracellular Redox Homeostasis. Small. https://doi.org/10.1002/smll.202407676
Vancouver
Lu W, Wang W, Gong Y, Li J, Zhou Y, Yang Y. A Noncationic Biocatalytic Nanobiohybrid Platform for Cytosolic Protein Delivery Through Controlled Perturbation of Intracellular Redox Homeostasis. Small. 2024. doi:10.1002/smll.202407676
BibTeX
@article{Lu2024,
author = {Lu, Wanyue and Wang, Weidong and Gong, Yimin and Li, Jianing and Zhou, Yaming and Yang, Yannan},
title = {A Noncationic Biocatalytic Nanobiohybrid Platform for Cytosolic Protein Delivery Through Controlled Perturbation of Intracellular Redox Homeostasis},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202407676}
}
EUVIMED